Twinbeech Capital LP Seagen Inc. Transaction History

Twinbeech Capital LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$135.08 - $161.1 $804,806 - $959,833	-5,958 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$137.51 - $190.8 $825 - $1,144	6 Added 0.1%	5,958 $827,000
Q4 2020 Feb 16, 2021	BUY	$164.63 - $211.93 $979,877 - $1.26 Million	5,952 New	5,952 $1.04 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.